{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:49:55Z","timestamp":1792651795442,"version":"4.5.0"},"reference-count":91,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.molmed.2020.03.003","type":"journal-article","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T19:55:21Z","timestamp":1585943721000},"page":"874-887","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Blocking Signalopathic Events to Treat Cerebral Cavernous Malformations"],"prefix":"10.1016","volume":"26","author":[{"given":"Salim","family":"Abdelilah-Seyfried","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Tournier-Lasserve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Brent","family":"Derry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2020.03.003_bb0005","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/13815","article-title":"Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas","volume":"23","author":"Laberge-le Couteulx","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2020.03.003_bb0010","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1086\/380314","article-title":"Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations","volume":"73","author":"Liquori","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2020.03.003_bb0015","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1086\/426952","article-title":"Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations","volume":"76","author":"Bergametti","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2020.03.003_bb0020","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/neuros\/nyy539","article-title":"Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial","volume":"85","author":"Polster","year":"2019","journal-title":"Neurosurgery"},{"key":"10.1016\/j.molmed.2020.03.003_bb0025","article-title":"Effect of simvastatin on permeability in cerebral cavernous malformation type 1 patients: results from a pilot small randomized controlled clinical trial","author":"Mabray","year":"2019","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.molmed.2020.03.003_bb0030","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: statistical study of retinoblastoma","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2020.03.003_bb0035","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/hmg\/ddn430","article-title":"Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis","volume":"18","author":"Akers","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2020.03.003_bb0040","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1093\/hmg\/ddu153","article-title":"Lesions from patients with sporadic cerebral cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesis","volume":"23","author":"McDonald","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2020.03.003_bb0045","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/hmg\/ddn420","article-title":"A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells","volume":"18","author":"Pagenstecher","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2020.03.003_bb0050","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1242\/dev.02469","article-title":"Santa and valentine pattern concentric growth of cardiac myocardium in the zebrafish","volume":"133","author":"Mably","year":"2006","journal-title":"Development"},{"key":"10.1016\/j.molmed.2020.03.003_bb0055","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/j.cub.2003.11.055","article-title":"Heart of glass regulates the concentric growth of the heart in zebrafish","volume":"13","author":"Mably","year":"2003","journal-title":"Curr. Biol."},{"key":"10.1016\/j.molmed.2020.03.003_bb0060","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1093\/hmg\/ddn142","article-title":"Ccm1 cell autonomously regulates endothelial cellular morphogenesis and vascular tubulogenesis in zebrafish","volume":"17","author":"Hogan","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molmed.2020.03.003_bb0065","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1242\/dmm.001263","article-title":"Tissue-specific conditional CCM2 knockout mice establish the essential role of endothelial CCM2 in angiogenesis: implications for human cerebral cavernous malformations","volume":"2","author":"Boulday","year":"2009","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.molmed.2020.03.003_bb0070","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nm.1918","article-title":"Regulation of cardiovascular development and integrity by the heart of glass-cerebral cavernous malformation protein pathway","volume":"15","author":"Kleaveland","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2020.03.003_bb0075","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1172\/JCI39679","article-title":"CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations","volume":"120","author":"Zheng","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2020.03.003_bb0080","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ydbio.2011.12.006","article-title":"Ccm3 functions in a manner distinct from Ccm1 and Ccm2 in a zebrafish model of CCM vascular disease","volume":"362","author":"Yoruk","year":"2012","journal-title":"Dev. Biol."},{"key":"10.1016\/j.molmed.2020.03.003_bb0085","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.devcel.2014.12.016","article-title":"Regulation of \u03b21 integrin-Klf2-mediated angiogenesis by CCM proteins","volume":"32","author":"Renz","year":"2015","journal-title":"Dev. Cell"},{"key":"10.1016\/j.molmed.2020.03.003_bb0090","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.devcel.2014.12.009","article-title":"The cerebral cavernous malformation pathway controls cardiac development via regulation of endocardial MEKK3 signaling and KLF expression","volume":"32","author":"Zhou","year":"2015","journal-title":"Dev. Cell"},{"key":"10.1016\/j.molmed.2020.03.003_bb0095","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1161\/CIRCRESAHA.118.313970","article-title":"Cerebral cavernous malformations develop through clonal expansion of mutant endothelial cells","volume":"123","author":"Detter","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.molmed.2020.03.003_bb0100","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1038\/s41467-019-10707-x","article-title":"Endothelial cell clonal expansion in the development of cerebral cavernous malformations","volume":"10","author":"Malinverno","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2020.03.003_bb0105","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/cr.2016.85","article-title":"Identification of blood vascular endothelial stem cells by the expression of protein C receptor","volume":"26","author":"Yu","year":"2016","journal-title":"Cell Res."},{"key":"10.1016\/j.molmed.2020.03.003_bb0110","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/CIRCRESAHA.117.312310","article-title":"Clonal expansion of endothelial cells contributes to ischemia-induced neovascularization","volume":"122","author":"Manavski","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.molmed.2020.03.003_bb0115","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/stem.2566","article-title":"Peg3\/PW1 is a marker of a subset of vessel associated endothelial progenitors","volume":"35","author":"Malinverno","year":"2017","journal-title":"Stem Cells"},{"key":"10.1016\/j.molmed.2020.03.003_bb0120","doi-asserted-by":"crossref","first-page":"126167","DOI":"10.1172\/jci.insight.126167","article-title":"Comprehensive transcriptome analysis of cerebral cavernous malformation across multiple species and genotypes","volume":"4","author":"Koskim\u00e4ki","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.molmed.2020.03.003_bb0125","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nature17178","article-title":"Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2\/4 signalling","volume":"532","author":"Zhou","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2020.03.003_bb0130","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/ncb1071","article-title":"Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock","volume":"5","author":"Uhlik","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.molmed.2020.03.003_bb0135","doi-asserted-by":"crossref","first-page":"6","DOI":"10.15252\/emmm.201505433","article-title":"KLF4 is a key determinant in the development and progression of cerebral cavernous malformations","volume":"8","author":"Cuttano","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.molmed.2020.03.003_bb0140","doi-asserted-by":"crossref","first-page":"7937","DOI":"10.1038\/ncomms8937","article-title":"Structure and vascular function of MEKK3-cerebral cavernous malformations 2 complex","volume":"6","author":"Fisher","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2020.03.003_bb0145","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1038\/s41467-019-09829-z","article-title":"A conserved CCM complex promotes apoptosis non-autonomously by regulating zinc homeostasis","volume":"10","author":"Chapman","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2020.03.003_bb0150","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nature12207","article-title":"EndMT contributes to the onset and progression of cerebral cavernous malformations","volume":"498","author":"Maddaluno","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2020.03.003_bb0155","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/CIRCRESAHA.118.314300","article-title":"CDC42 deletion elicits cerebral vascular malformations via increased MEKK3-dependent KLF4 expression","volume":"124","author":"Castro","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.molmed.2020.03.003_bb0160","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1161\/STROKEAHA.115.011867","article-title":"Endothelial cells lining sporadic cerebral cavernous malformation cavernomas undergo endothelial-to-mesenchymal transition","volume":"47","author":"Bravi","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.molmed.2020.03.003_bb0165","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1126\/science.aas9432","article-title":"Endothelial cell transitions","volume":"362","author":"Dejana","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.molmed.2020.03.003_bb0170","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1084\/jem.20171178","article-title":"Thrombospondin1 (TSP1) replacement prevents cerebral cavernous malformations","volume":"214","author":"Lopez-Ramirez","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2020.03.003_bb0175","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/nm.4169","article-title":"Endothelial exocytosis of angiopoietin-2 resulting from CCM3 deficiency contributes to cerebral cavernous malformation","volume":"22","author":"Jenny Zhou","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2020.03.003_bb0180","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/CIRCRESAHA.110.217257","article-title":"Integrin cytoplasmic domain-associated protein-1 attenuates sprouting angiogenesis","volume":"107","author":"Br\u00fctsch","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.molmed.2020.03.003_bb0185","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.28939","article-title":"Heg1 and Ccm1\/2 proteins control endocardial mechanosensitivity during zebrafish valvulogenesis","volume":"7","author":"Donat","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.molmed.2020.03.003_bb0190","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1161\/STROKEAHA.114.007512","article-title":"Cerebral cavernous malformation-1 protein controls DLL4-Notch3 signaling between the endothelium and pericytes","volume":"46","author":"Schulz","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.molmed.2020.03.003_bb0195","doi-asserted-by":"crossref","first-page":"12640","DOI":"10.1073\/pnas.1000132107","article-title":"Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling","volume":"107","author":"W\u00fcstehube","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2020.03.003_bb0200","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/jcmm.12022","article-title":"Loss of CCM3 impairs DLL4-Notch signalling: implication in endothelial angiogenesis and in inherited cerebral cavernous malformations","volume":"17","author":"You","year":"2013","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.molmed.2020.03.003_bb0205","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1111\/jcmm.13105","article-title":"EphB4 forward signalling mediates angiogenesis caused by CCM3\/PDCD10-ablation","volume":"21","author":"You","year":"2017","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.molmed.2020.03.003_bb0210","doi-asserted-by":"crossref","DOI":"10.3171\/2010.5.FOCUS1090","article-title":"Differential angiogenesis function of CCM2 and CCM3 in cerebral cavernous malformations","volume":"29","author":"Zhu","year":"2010","journal-title":"Neurosurg. Focus."},{"key":"10.1016\/j.molmed.2020.03.003_bb0215","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809155","article-title":"Systematic pharmacological screens uncover novel pathways involved in cerebral cavernous malformations","volume":"10","author":"Otten","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.molmed.2020.03.003_bb0220","doi-asserted-by":"crossref","first-page":"8421","DOI":"10.1073\/pnas.1501352112","article-title":"Sulindac metabolites decrease cerebrovascular malformations in CCM3-knockout mice","volume":"112","author":"Bravi","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2020.03.003_bb0225","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1242\/dmm.003293","article-title":"Rap1 and its effector KRIT1\/CCM1 regulate beta-catenin signaling","volume":"3","author":"Glading","year":"2010","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.molmed.2020.03.003_bb0230","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1083\/jcb.200705175","article-title":"KRIT-1\/CCM1 is a Rap1 effector that regulates endothelial cell cell junctions","volume":"179","author":"Glading","year":"2007","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.molmed.2020.03.003_bb0235","doi-asserted-by":"crossref","first-page":"11760","DOI":"10.1074\/jbc.C109.097220","article-title":"Rho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype","volume":"285","author":"Borikova","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2020.03.003_bb0240","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1515\/hsz-2012-0243","article-title":"Cerebral cavernous malformation is a vascular disease associated with activated RhoA signaling","volume":"394","author":"Richardson","year":"2013","journal-title":"Biol. Chem."},{"key":"10.1016\/j.molmed.2020.03.003_bb0245","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nm.1911","article-title":"The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases","volume":"15","author":"Whitehead","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.molmed.2020.03.003_bb0250","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1083\/jcb.201303044","article-title":"CCM1-ICAP-1 complex controls \u03b21 integrin-dependent endothelial contractility and fibronectin remodeling","volume":"202","author":"Faurobert","year":"2013","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.molmed.2020.03.003_bb0255","doi-asserted-by":"crossref","first-page":"8296","DOI":"10.1038\/s41598-017-08373-4","article-title":"Up-regulation of NADPH oxidase-mediated redox signaling contributes to the loss of barrier function in KRIT1 deficient endothelium","volume":"7","author":"Goitre","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2020.03.003_bb0260","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.15252\/emmm.201505316","article-title":"Defective autophagy is a key feature of cerebral cavernous malformations","volume":"7","author":"Marchi","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.molmed.2020.03.003_bb0265","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1074\/mcp.M800266-MCP200","article-title":"A PP2A phosphatase high density interaction network identifies a novel striatin-interacting phosphatase and kinase complex linked to the cerebral cavernous malformation 3 (CCM3) protein","volume":"8","author":"Goudreault","year":"2009","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.molmed.2020.03.003_bb0270","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1016\/j.celrep.2018.08.039","article-title":"Interrogating the ccm-3 Gene Network","volume":"24","author":"Lant","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2020.03.003_bb0275","doi-asserted-by":"crossref","first-page":"6449","DOI":"10.1038\/ncomms7449","article-title":"CCM-3\/STRIPAK promotes seamless tube extension through endocytic recycling","volume":"6","author":"Lant","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2020.03.003_bb0280","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2000722","article-title":"Stabilization of VEGFR2 signaling by cerebral cavernous malformation 3 is critical for vascular development","volume":"3","author":"He","year":"2010","journal-title":"Sci. Signal."},{"key":"10.1016\/j.molmed.2020.03.003_bb0285","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.devcel.2013.09.021","article-title":"A network of interactions enables CCM3 and STK24 to coordinate UNC13D-driven vesicle exocytosis in neutrophils","volume":"27","author":"Zhang","year":"2013","journal-title":"Dev. Cell"},{"key":"10.1016\/j.molmed.2020.03.003_bb0290","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.devcel.2013.05.002","article-title":"Focal defects in single-celled tubes mutant for cerebral cavernous malformation 3, GCKIII, or NSF2","volume":"25","author":"Song","year":"2013","journal-title":"Dev. Cell"},{"key":"10.1016\/j.molmed.2020.03.003_bb0295","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.cub.2017.02.028","article-title":"CCM-3 promotes C. elegans germline development by regulating vesicle trafficking cytokinesis and polarity","volume":"27","author":"Pal","year":"2017","journal-title":"Curr. Biol."},{"key":"10.1016\/j.molmed.2020.03.003_bb0300","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1084\/jem.20091258","article-title":"Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity","volume":"207","author":"Stockton","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2020.03.003_bb0305","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1161\/STROKEAHA.118.024058","article-title":"Rho kinase inhibition blunts lesion development and hemorrhage in murine models of aggressive Pdcd10\/Ccm3 disease","volume":"50","author":"Shenkar","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.molmed.2020.03.003_bb0310","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1161\/CIRCULATIONAHA.114.010403","article-title":"Strategy for identifying repurposed drugs for the treatment of cerebral cavernous malformation","volume":"131","author":"Gibson","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.molmed.2020.03.003_bb0315","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1073\/pnas.1702942114","article-title":"Combined HMG-COA reductase and prenylation inhibition in treatment of CCM","volume":"114","author":"Nishimura","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2020.03.003_bb0320","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/0009922813492885","article-title":"Propranolol for cerebral cavernous angiomatosis: a magic bullet","volume":"53","author":"Berti","year":"2014","journal-title":"Clin. Pediatr. (Phila)"},{"key":"10.1016\/j.molmed.2020.03.003_bb0325","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/j.jaad.2013.11.006","article-title":"Successful treatment of multifocal intracerebral and spinal hemangiomas with propranolol","volume":"70","author":"Miquel","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.molmed.2020.03.003_bb0330","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jns.2016.04.053","article-title":"Propranolol stops progressive multiple cerebral cavernoma in an adult patient","volume":"367","author":"Reinhard","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.molmed.2020.03.003_bb0335","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.wneu.2015.11.003","article-title":"Propranolol treatment of cavernous malformations with symptomatic hemorrhage","volume":"88","author":"Zabramski","year":"2016","journal-title":"World Neurosurg."},{"key":"10.1016\/j.molmed.2020.03.003_bb0340","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.43026","article-title":"R-propranolol is a small molecule inhibitor of the SOX18 transcription factor in a rare vascular syndrome and hemangioma","volume":"8","author":"Overman","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.molmed.2020.03.003_bb0345","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41698-019-0099-9","article-title":"Propranolol exhibits activity against hemangiomas independent of beta blockade","volume":"3","author":"Sasaki","year":"2019","journal-title":"NPJ Precis. Oncol."},{"key":"10.1016\/j.molmed.2020.03.003_bb0350","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1084\/jem.20110571","article-title":"Developmental timing of CCM2 loss influences cerebral cavernous malformations in mice","volume":"208","author":"Boulday","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molmed.2020.03.003_bb0355","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/ana.20947","article-title":"Genotype-phenotype correlations in cerebral cavernous malformations patients","volume":"60","author":"Denier","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.molmed.2020.03.003_bb0360","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/jcmm.14773","article-title":"VEGF signalling enhances lesion burden in KRIT1 deficient mice","volume":"24","author":"DiStefano","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.molmed.2020.03.003_bb0365","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/gim.2014.97","article-title":"Exceptional aggressiveness of cerebral cavernous malformation disease associated with PDCD10 mutations","volume":"17","author":"Shenkar","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.molmed.2020.03.003_bb0370","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nature22075","article-title":"Endothelial TLR4 and the microbiome drive cerebral cavernous malformations","volume":"545","author":"Tang","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2020.03.003_bb0375","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw3521","article-title":"Distinct cellular roles for PDCD10 define a gut-brain axis in cerebral cavernous malformation","volume":"11","author":"Tang","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.molmed.2020.03.003_bb0380","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s11481-016-9670-0","article-title":"B-cell depletion reduces the maturation of cerebral cavernous malformations in murine models","volume":"11","author":"Shi","year":"2016","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.molmed.2020.03.003_bb0385","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1172\/JCI83083","article-title":"Endothelial fluid shear stress sensing in vascular health and disease","volume":"126","author":"Baeyens","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2020.03.003_bb0390","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1091\/mbc.E14-11-1522","article-title":"Biomechanics of vascular mechanosensation and remodeling","volume":"27","author":"Baeyens","year":"2016","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.molmed.2020.03.003_bb0395","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1161\/CIRCRESAHA.119.315076","article-title":"Blood flow suppresses vascular anomalies in a zebrafish model of cerebral cavernous malformations","volume":"125","author":"R\u00f6del","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.molmed.2020.03.003_bb0400","doi-asserted-by":"crossref","first-page":"165519","DOI":"10.1016\/j.bbadis.2019.07.013","article-title":"Low fluid shear stress conditions contribute to activation of cerebral cavernous malformation signalling pathways","volume":"1865","author":"Li","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.molmed.2020.03.003_bb0405","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/ng.272","article-title":"Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations","volume":"41","author":"Limaye","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2020.03.003_bb0410","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.ajhg.2019.09.010","article-title":"Somatic mutations in vascular malformations of hereditary hemorrhagic telangiectasia result in bi-allelic loss of ENG or ACVRL1","volume":"105","author":"Snellings","year":"2019","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2020.03.003_bb0415","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/jmedgenet-2016-104432","article-title":"De novo mutations in CBL causing early-onset paediatric moyamoya angiopathy","volume":"54","author":"Guey","year":"2017","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.molmed.2020.03.003_bb0420","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1086\/379793","article-title":"Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations","volume":"73","author":"Eerola","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2020.03.003_bb0425","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ajhg.2017.01.018","article-title":"Somatic MAP2K1 mutations are associated with extracranial arteriovenous malformation","volume":"100","author":"Couto","year":"2017","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.molmed.2020.03.003_bb0430","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1056\/NEJMoa1709449","article-title":"Somatic activating KRAS mutations in arteriovenous malformations of the brain","volume":"378","author":"Nikolaev","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2020.03.003_bb0435","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1474-4422(07)70053-4","article-title":"Genetics of cavernous angiomas","volume":"6","author":"Labauge","year":"2007","journal-title":"2Lancet Neurol."},{"key":"10.1016\/j.molmed.2020.03.003_bb0440","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/neuros\/nyx091","article-title":"Synopsis of guidelines for the clinical management of cerebral cavernous malformations: consensus recommendations based on systematic literature review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel","volume":"80","author":"Akers","year":"2017","journal-title":"Neurosurgery"},{"key":"10.1016\/j.molmed.2020.03.003_bb0445","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000350042","article-title":"CCM3 mutations are associated with early-onset cerebral hemorrhage and multiple meningiomas","volume":"4","author":"Riant","year":"2013","journal-title":"Mol. Syndromol."},{"key":"10.1016\/j.molmed.2020.03.003_bb0450","article-title":"A brain-targeted orally available ROCK2 inhibitor benefits mild and aggressive cavernous angioma disease","author":"McKerracher","year":"2019","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.molmed.2020.03.003_bb0455","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aau0731","article-title":"Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations","volume":"4","author":"Choi","year":"2018","journal-title":"Sci. Adv."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147149142030068X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147149142030068X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:19:16Z","timestamp":1761463156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147149142030068X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":91,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S147149142030068X"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2020.03.003","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blocking Signalopathic Events to Treat Cerebral Cavernous Malformations","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2020.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}